Indivior plc (INDV) ORD USD0.5

Sell:740.50pBuy:743.00pNo change

Prices delayed by at least 15 minutes
Sell:740.50p
Buy:743.00p
Change:No change
Prices delayed by at least 15 minutes
Sell:740.50p
Buy:743.00p
Change:No change
Prices delayed by at least 15 minutes

Company Information

About this company

Indivior PLC is a global pharmaceutical company engaged in developing medicines to treat substance-use disorders (SUD). The Company provides treatment for addiction, including SUBLOCADE (buprenorphine extended-release) injection for subcutaneous use, a long-acting injectable (LAI) for opioid use disorder and OPVEE (Nalmefene) nasal spray for opioid overdose recovery. Its core products include SUBOXONE Film, SUBOXONE Tablet, SUBUTEX Tablet, OPVEE (nalmefene), and SUBLOCADE. SUBOXONE Film is a buprenorphine and naloxone sublingual film. SUBOXONE Tablet is a buprenorphine and naloxone sublingual tablet. SUBUTEX Tablet is a buprenorphine sublingual tablet. SUBOXONE Film, SUBOXONE Tablet, SUBUTEX Tablet, and SUBLOCADE are treatments for opioid use disorder (OUD). In addition to its commercially available products, its product pipeline includes two drug candidates for the treatment of OUD. The Company sells its products in the United States and in other selected areas of the world.

Key people

Mark Crossley
Chief Executive Officer, Executive Director
Jon Fogle
Chief Human Resource Officer
Christian Heidbreder
Chief Scientific Officer
Cynthia Cetani
Chief Integrity and Compliance Officer
Jeffrey W. Burris
Chief Legal Officer
Vishal Kalia
Chief Impact and Strategy Officer
Richard Simkin
Chief Commercial Officer
Hillel West
Chief Manufacturing and Supply Officer
Kathryn Barbara Hudson
Company Secretary
David E. Wheadon
Non-Executive Independent Chairman of the Board
Jerome J. Lande
Non-Executive Director
Peter Bains
Non-Executive Independent Director
Joseph J. Ciaffoni
Chief Executive Officer
Keith Humphreys
Non-Executive Independent Director
Click to see more

Key facts

  • EPIC
    INDV
  • Location
    United States
  • Sector
    Healthcare
  • Industry
    Biotechnology & Drugs
  • ISIN
    GB00BN4HT335
  • Market cap
    £921.21m
  • Employees
    1,030
  • Shares in issue
    124.76m
  • Exchange
    London Stock Exchange (LON)
  • Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.